CAT# | CP26337 |
CAS | 136092-80-3 |
Synonyms/Alias | Boc-N-Me-Allo-Ile-OH;136092-80-3;Boc-Mealloile-OH;ZINC2391130;AJ-35723;Z5640;K-4338 |
M.F/Formula | C12H23NO4 |
M.W/Mr. | 245.32 |
Size | 1 g;5 g; | InChI | 1S/C12H23NO4/c1-7-8(2)9(10(14)15)13(6)11(16)17-12(3,4)5/h8-9H,7H2,1-6H3,(H,14,15)/t8-,9+/m1/s1 | InChI Key | HTBIAUMDQYXOFG-BDAKNGLRSA-N | Canonical SMILES | CCC(C)C(C(=O)O)N(C)C(=O)OC(C)(C)C |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CP25507 | Boc-12-Ado-OH | Inquiry | ||
CP26162 | Fmoc-Ser(tBu)-OPfp | Inquiry | ||
CP25954 | Boc-L-Pra-OH*DCHA | Inquiry | ||
CP20701 | Boc-3-(3-benzothienyl)-D-alanine | Inquiry | ||
CP12607 | Fmoc-2,3-Difluoro-D-Phenylalanine | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Trimetazidine is a partial fatty acid oxidation inhibitor that inhibits 3-ketoacyl CoA thiolase, one of the enzymes of fatty ...
Octreotide, a long-acting structural derivative of somatostatins, is a synthetic peptide analog of somatostatin with the same ...
Ornithoctonus huwena, Chinese tarantula, is one of the most venomous spiders in China, and its venom can kill in ...
ICl 154,129 is a new compound that shows selectivity as an antagonist of [Leu5]enkephalin and [D-AIa2, D-Leu5]en ...
Timonacic's chemical name, L-Syrosin-4, is a new anti-tumor drug that converts cancer cells into normal cells. E ...